ARTICLE | Clinical News
RG7334: Phase I start
May 24, 2010 7:00 AM UTC
Roche began an open-label, dose-ranging, European Phase I imaging trial to evaluate intravenous RG7334 in up to 50 patients. The start triggers a €10 million ($12.3 million) milestone payment to Throm...